Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
venerdì, ottobre 30
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Vertex Pharmaceuticals Inc
VRTX
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$540.00
10.31
1.95%
Ult. Agg.: Oct 29, 7:40 PM
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
Utili:
I risultati di Q3 2026 tra 4 giorni da adesso in lun nov 2nd, dopo la chiusura del mercato
Conference call:
Conference call programmata per tra 4 giorni alle 4:30 PM
Clicca per vedere il webcast
Vertex Pharmaceuticals Financials
Vertex Pharmaceuticals (VRTX) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Vertex Pharmaceuticals Raises FY2026 Sales Guidance from $12.950B-$13.100B to $13.100B-$13.200B vs $13.065B Est
Vertex Pharmaceuticals (NASDAQ:VRTX) raises FY2026 sales outlook from $12.950 billion-$13.100 billion to $13.100 billion-$13.200 billion vs $13.065 billion estimate.
Benzinga Newsdesk
PRO
Vertex Pharmaceuticals Q2 Adj. EPS $4.73, Inline, Sales $3.334B Beat $3.232B Estimate
Vertex Pharmaceuticals (NASDAQ:VRTX) reported quarterly earnings of $4.73 per share which met the analyst consensus estimate. This is a 4.65 percent increase over earnings of $4.52 per share from the same period last
Benzinga Newsdesk
Tyson Foods, Marriott And 3 Stocks To Watch Heading Into Monday
U.S. stock futures up, focus on earnings from Tyson Foods, Marriott, Universal Logistics, Williams Companies, and Vertex Pharmaceuticals.
Avi Kapoor
Nasdaq Jumps 1% as Amazon Shares Surge: Investor Sentiment Improves, But Greed Index Remains in 'Fear' Zone
CNN Money Fear & Greed index improved while remaining in 'Fear' zone on Friday. Amazon up 15%, Apple down 7%.
Avi Kapoor
These Analysts Revise Their Forecasts On Vertex Pharmaceuticals After Q1 Earnings
Vertex Pharmaceuticals Inc reported mixed financial results for Q1, with revenue of $2.99B and adjusted EPS of $4.47. CEO confident in future growth and value creation. Stock fell 2.7% and analysts revised price targets. Considering buying VRTX? Analysts have Outperform ratings and lowered price targets.
Avi Kapoor
Vertex Pharmaceuticals Posts Mixed Q1; Investors Focus On Non-CF Pipeline For Growth
Vertex Pharma posts revenue beat but misses EPS expectations. CF franchise remains strong, says Needham analyst.
Priya Nigam
